Why the Mach7 (ASX:M7T) share price is zooming 9% higher today

The Mach7 Technologies Ltd (ASX:M7T) share price is zooming higher on Friday after announcing a major new contract win…

The Mach7 Technologies Ltd (ASX: M7T) share price has stormed higher this morning following the release of an announcement.

In early trade the enterprise imaging platform provider's shares are up 9% to $1.11.

What did Mach7 announce?

This morning Mach7 announced that it has signed a seven-year contract with Trinity Health for the license and associated support services for its eUnity enterprise viewer. The total value of this contract is A$5.26 million.

Trinity Health is the fifth largest healthcare Integrated Delivery Network (IDN) in the United States and this contract will see Mach7's eUnity enterprise viewer being installed across multiple facilities within its 92 hospitals located across 22 US states.

It serves approximately 30 million people across these states, employs about 123,000 colleagues, including 6,800 employed physicians and clinicians, and has annual operating revenues of US$18.8 billion and assets of US$30.5 billion.

What now?

According to the release, the software deployment will occur in stages as software licenses are ordered by Trinity Health.

Mach7 expects to receive the first software license orders during the current quarter, and the majority of the orders within FY 2021.

Management advised that the associated software license revenue is likely to be recognised very shortly after the order is received, upon the license delivery and software deployment. Whereas support and maintenance fees will commence one year after deployment and will continue for a period of six years.

Mach7's CEO, Mike Lampron, commented: "Mach7 is delighted to be partnering with Trinity Health, a respected and leading health care provider in the U.S."

"This is Mach7's first material contract award since our acquisition of Client Outlook and highlights our investment thesis around the importance of a world-class Enterprise Viewer to an Enterprise Imaging Strategy. This announcement represents a launching point for a larger and more integrated relationship with Trinity involving our vendor neutral archive and diagnostic viewing solutions," he added.

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and recommends MACH7 FPO. The Motley Fool Australia has recommended MACH7 FPO. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on ASX Share Market News

Red buy button on an Apple keyboard with a finger on it.
Broker Notes

Expert names Woodside and CSL shares as top buys today

A leading expert says now is the time to buy CSL and Woodside shares. But why?

Read more »

Signs of asset classes on a newspaper which says 'Where to invest your money?'.
Opinions

Where I'd invest in ASX shares after the recent RBA rate rise

These investments now look very good value to me.

Read more »

A male sharemarket analyst sits at his desk looking intently at his laptop with two other monitors next to him showing stock price movements
Broker Notes

Buy, hold, sell: Telix Pharmaceuticals, Qualitas, Greatland Resources shares

Here's what Mark Gardner from MPC Markets thinks of these three ASX shares.

Read more »

Two brokers analysing the share price with the woman pointing at the screen and man talking on a phone.
Broker Notes

Buy, hold, sell: Premier Investments, New Hope, Xero shares

We review three fresh buy, hold, and sell calls from expert market analysts.

Read more »

Happy businessman fist pumping while looking at a tablet.
Broker Notes

Up 120%, is it too late to buy Codan shares?

Bell Potter thinks this high-flying stock could keep rising.

Read more »

A man looking at his laptop and thinking.
ASX Share Market News

5 things to watch on the ASX 200 on Wednesday

Here's what to expect on the local market on hump day.

Read more »

A female runner climbs a set of stairs, running with strength and pace.
Opinions

Can the Xero share price climb back to $100?

Could Xero shares finally be ready for a comeback?

Read more »

Medical workers examine an x-ray or scan in a hospital laboratory.
Broker Notes

This ASX biotech could nearly triple in value Bell Potter says

A big development in the US is good news for this company.

Read more »